Yi-Han Chang is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of immunology through his innovative research and patents. With a total of 2 patents, Chang's work focuses on serum immunoregulatory polypeptides and their applications.

Latest Patents

Chang's latest patents include the development of previously unisolated serum immunoregulatory polypeptides (SIPs) with a molecular weight ranging from approximately 14,000 to 31,000. These SIPs can be extracted from the hemorrhagic serum of mammals and have demonstrated the ability to activate suppressor T-cells while suppressing lymphocyte proliferation and interleukin production. Notably, there is significant homology between SIPs across different mammalian species. Additionally, the amino acid sequence of an SIP weighing about 16,000 is provided, along with the identification of immunosuppressive polypeptides characterized by a specific formula.

Career Highlights

Yi-Han Chang is affiliated with the University of California, where he continues to advance his research in immunology. His work has garnered attention for its potential applications in therapeutic settings, particularly in the modulation of immune responses.

Collaborations

Chang collaborates with Edward Abraham, contributing to the advancement of knowledge in the field of immunoregulatory polypeptides.

Conclusion

Yi-Han Chang's innovative work in the realm of immunoregulatory polypeptides highlights his role as a significant contributor to immunology. His patents reflect a commitment to advancing scientific understanding and potential therapeutic applications.